Issue: Vojnosanit Pregl 2014; Vol. 71 (No. 2)

Cost-effectiveness analysis of tocilizumab in combination with methotrexate for rheumatoid arthritis: A Markov model based on data from Serbia, country in socioeconomic transition

Authors:
Marina Kostić, Snežana Jovanović, Marina Tomović, Marija Popović Milenković, Slobodan M. Janković

Download full articele PDF

Recent studies have shown that biological treatments for rheumatoid arthritis can change the course of rheumatoid arthritis and improve functional ability of patients with rheumatoid arthritis. In spite of this fact, use of biological therapy is still limited by high prices of these medicines, especially in countries in socioeconomic transition